William Hiatt in conversation with Ulf Landmesser
NV1FGF Gene Therapy on Amputation-Free Survival in Critical Lib Ischemia – Phase 3 Randomized...
» More
William Hiatt in conversation with Ulf Landmesser
NV1FGF Gene Therapy on Amputation-Free Survival in Critical Lib Ischemia – Phase 3 Randomized Double-Blind Placebo-Controlled Trial